EDGAR Filing Documents for 0001193125-20-034397

Form 8-K - Current report:

SEC Accession No. 0001193125-20-034397

Filing Date

2020-02-13

Accepted

2020-02-13 08:51:36

Documents

Period of Report

2020-02-12

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d885122d8k.htm	8-K	23205
2	EX-1.1	d885122dex11.htm	EX-1.1	339222
3	EX-99.1	d885122dex991.htm	EX-99.1	10486
4	GRAPHIC	g885122g0213080233046.jpg	GRAPHIC	3852
	Complete submission text file	0001193125-20-034397.txt		379732

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140

Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340

Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)